Liver Involvement in Celiac Disease and Immune-Mediated Diseases of the Small Bowel
- PMID: 40679061
- PMCID: PMC12272813
- DOI: 10.1111/liv.70206
Liver Involvement in Celiac Disease and Immune-Mediated Diseases of the Small Bowel
Abstract
Disorders of the hepatobiliary system are commonly associated with gastrointestinal (GI) diseases. The GI and hepatobiliary systems interact through the portal vein system and enterohepatic circulation, creating a gut-liver axis that allows for a complex multidirectional interplay between immune, hormonal, dietary and environmental luminal factors that include the gut microbiota. This interaction may underlie the liver affection in autoimmune and immune-mediated small bowel diseases through a variety of pathways that include autoimmune, metabolic, immune-mediated, and/or iatrogenic mechanisms. Despite evidence of a gut-liver axis and co-morbid liver associations with small bowel diseases, the clinical implications and how these conditions should be clinically managed remain unclear. In this narrative review, we describe the hepato-biliary manifestations associated with chronic immune-mediated enteropathies of the small bowel in adults, with particular focus on CeD and Crohn's disease.
Keywords: Crohn's disease; autoimmune hepatitis; celiac disease; small bowel.
© 2025 The Author(s). Liver International published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.Clin Gastroenterol Hepatol. 2025 Jul;23(8):1291-1302. doi: 10.1016/j.cgh.2025.02.015. Epub 2025 May 19. Clin Gastroenterol Hepatol. 2025. PMID: 40387691 Review.
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
-
LINE-1 hypomethylation characterizes the inflammatory response in coeliac disease associated-intestinal mucosa and small bowel adenocarcinomas.J Pathol. 2025 Jan;265(1):99-109. doi: 10.1002/path.6371. Epub 2024 Nov 27. J Pathol. 2025. PMID: 39601242 Free PMC article.
-
Diagnostic Challenges in Enteropathies: A Histopathological Review.Diagnostics (Basel). 2025 Jun 13;15(12):1511. doi: 10.3390/diagnostics15121511. Diagnostics (Basel). 2025. PMID: 40564832 Free PMC article. Review.
-
Natalizumab for induction of remission in Crohn's disease.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006097. doi: 10.1002/14651858.CD006097. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006097. doi: 10.1002/14651858.CD006097.pub2. PMID: 16856112 Updated.
References
-
- Pinto‐Sanchez M. I., Seiler C. L., Santesso N., et al., “Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta‐Analysis,” Gastroenterology 159 (2020): 884–903.e31. - PubMed
-
- Roggenbuck D., Goihl A., Sowa M., et al., “Human Glycoprotein‐2 Expressed in Brunner Glands—A Putative Autoimmune Target and Link Between Crohn's and Coeliac Disease,” Clinical Immunology 247 (2023): 109214. - PubMed
-
- Majumdar K., Sakhuja P., Puri A. S., Gaur K., Haider A., and Gondal R., “Coeliac Disease and the Liver: Spectrum of Liver Histology, Serology and Treatment Response at a Tertiary Referral Centre,” Journal of Clinical Pathology 71 (2018): 412–419. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical